A Phase 2 Study of Aflibercept and Chemotherapy as First Line Treatment for Metastatic Colorectal Cancer Assessable With DCE-US.
Phase of Trial: Phase II
Latest Information Update: 05 Feb 2018
Price : $35 *
At a glance
- Drugs Aflibercept (Primary) ; Fluorouracil; Folinic acid; Irinotecan
- Indications Colorectal cancer
- Focus Therapeutic Use
- Acronyms PULSAR
- 21 Jan 2017 Interim results (n=30) assessing safety and efficacy presented at the 2017 Gastrointestinal Cancers Symposium.
- 15 Feb 2016 Planned End Date changed from 1 Apr 2017 to 1 Jul 2017 as reported by ClinicalTrials.gov record.
- 15 Feb 2016 Planned primary completion date changed from 1 Oct 2016 to 1 Jul 2017 as reported by ClinicalTrials.gov record.